The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

StocksMediumUpdated•Originally published 28 April 2026•Updated 28 April 2026•

1 min read

Zimmer Biomet Beats Q1 Estimates Amid CFO Departure Announcement

Key Facts

1Zimmer Biomet reported Q1 adjusted earnings of $2.09 per share, a 15.5% year-over-year increase.

2The company's earnings beat Wall Street estimates of $1.86 per share.

Zimmer Biomet Holdings reported adjusted Q1 earnings of $2.09 per share, beating the $1.86 analyst consensus. However, major firms have since lowered their price targets, with Stifel cutting its target to $105 and Truist Securities dropping its outlook to $92. This analyst caution stems from concerns over earnings quality, as results were bolstered by a one-time tariff refund benefit while facing headwinds from a nursing strike and account losses. Furthermore, the announced departure of the CFO has introduced additional uncertainty regarding the company's future financial leadership. Analysts suggest that the operational risks and non-recurring benefits may impact long-term sustainability. Markets remain focused on how the company will navigate these structural challenges and the upcoming leadership transition.

about 1 month ago

Version History

Version 1about 1 month ago

What changed: Updated the story to include price target cuts from Stifel and Truist Securities, highlighting concerns over earnings quality due to one-time benefits and operational risks.